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The promises of 
neurodegenerative disease 
modeling




The purpose of the study
• With the rise of the human lifespan has come the rise of age-related 
disorders, particularly neurodegenerative diseases that express 
themselves late in life such as Alzheimer’s disease (AD) and 
Parkinson’s disease (PD)
• However, age-related diseases also means more research spending in cancer 
treatments
• The paper seeks to (1) evaluate the role of molecular genetics in 
research studies and (2) examine the use of D. melanogaster (the 
common fruit fly)
Introduction
• Medical problems such as Parkinson’s disease pose a problem for 
both the individuals diagnosed with the diseases and those who have 
to take care of the affected individual
Stress for the 
individual Stress for the family
Stress for primary and 
secondary care takers
Take up hospital beds
More tax paper money 
for governmentally 
funded hospitals and 
health care systems
Introduction
• These stressors necessitate government involvement through 
research. 
• These research programs take up money that could be spent toward other 
programs such as Social Security and employee benefits
• The private sector could be delegated the task of conducting research
• However, this may mean fewer treatments for patients and less novelty in 
daily life
• Discussion question: Regarding research, are you happy with the 
government’s allocation of money? Should the government change 
the amount of spending it is putting towards research?
Introduction
• Before testing on human subjects, research is largely conducted on 
less-expensive and lower-risk species such as mice that mimic the 
human genome
• However, genetic engineering has also allowed us to edit the 
genomes of these species and mimic the conditions in individuals 
with altered genes (like in individuals with genetically-linked diseases)
Molecular genetics and the diversification of 
animal model organisms
• Besides the costs and ethical dilemmas, there are two main reasons 
why using animals with germ lines similar to those of humans is 
useful
• When the genome of these species is unaltered, they allow us to test whether 
various chemicals or treatments are useful to regular people
• When their genomes are edited, they allow us to mimic patients with 
preexisting conditions
• The latter has been made possible through genetic engineering
Molecular genetics and the diversification of 
animal model organisms
• Method 1: The use of recombinant DNA to splice DNA fragments into 
bacteria using plasmids and viral vectors
Molecular genetics and the diversification of 
animal model organisms
• Bacteria are single-celled organisms
• Method 2: The introduction of genetic engineering into single-celled 
species paved the way for the introduction of genetic engineering into 
multicellular organisms and ultimately humans
• The transgenic approach was introduced into mice in the early 1980s 
and eventually fruit flies later on
• These animal models have been instrumental in studying the 
neurodegenerative effects of Alzheimer’s, Parkinson’s, ALS, and 
Huntington’s disease
Molecular genetics and the diversification of 
animal model organisms
• Method 3: Genome sequencing allowed researchers to take a look at 
the genomes of various animals species such as nematodes and mice 
• This allows researchers to determine animal counterparts to humans 
that can fit within their realm of study
• Genome sequencing also reveals the degree to which genes have 
been preserved over the course of evolution
• Not only is the structure of the resulting proteins the same but also their 
function in those organisms
• This further affirms the use of animal models as human alternatives
Molecular genetics and the diversification of 
animal model organisms
• Method 4: Come up with DNA probes that can quantify the 
expression of certain genes in different organisms
• Even though we may share many of the same genes as mice (99% 
similarity), mice definitely express different genes that we do, leading 
to their different physiology and responses to treatments
• What this means is that animals cannot be the end-all-be-all of drug 
testing: human trials are required
Advantages and purpose of simpler 
organisms
• Simpler human alternatives have the following advantages:
• They are genetically similar to humans
• They do not pose as many ethical dilemmas (especially simpler organisms)
• They are less expensive to maintain
• Animals reproduce more often
• They produce more offspring
• They are more freely available
• However, animal models also have various disadvantages
Advantages and purpose of simpler 
organisms
• Disadvantages of animal models
• They do not perfectly mirror the human genome
• Some species (such as pigs) still pose ethical dilemmas
• At a large scale, high costs up-front
• High personal effort on the part of researchers (mice will not maintain themselves)
• The integration of animal models in research means that there are more barriers in 
introducing a new treatment to the public
• What side does the author err on?
• The author would suggest that the advantages outweigh the disadvantages
• With similar genomes, similar responses to treatments are ensured
• Animal testing is required for human approval
• They provide more in-depth insight as you can cut them up and observe them 
without ethical issues
Drosophila melanogaster as a model organism of 
choice to study neurodegenerative diseases
• So, animal models are effective
• Now, what animal should you use for neurodegenerative disorders?
• Mice have complex nervous systems, but they can pose ethical 
dilemmas and cost more to maintain and test on
• D. melanogaster has nerve cells exposed (eye), but they are difficult 
observe in vivo
• Nematodes are simple organisms, but they have primitive nervous 
systems
Drosophila melanogaster as a model organism of 
choice to study neurodegenerative diseases
Mouse Fruit Fly Nematode
• Most expensive to 
maintain and examine
• Difficult to manage
• Pose ethical dilemmas
• Complex nervous 
systems (70 million 
neurons)
• Easy to maintain
• Eyes can be examined 
for neurodegeneration
• Do not pose ethical 
dilemmas
• Relatively simple 
nervous systems 
(200,000 neurons)
• Easy to maintain and 
purchase
• Easy to genetically 
modify
• Do not pose ethical 
dilemmas
• Very simple nervous 
systems (302 neurons)
Drosophila melanogaster as a model organism of
choice to study neurodegenerative diseases
• Upon other advantages, D. melanogaster has several benefits over 
other organisms in modeling neurodegenerative diseases
• Easy to reproduce
• Many offspring
• ”At least 77% of the human disease-associated genes reported in the Online 
Mendelian Inheritance in man database have evolutionary similarities with 
Drosophila genes”
Drosophila and the study of 
neurodegeneration
• Fruit flies have been used for over 100 years in biological research, so 
they have a proven track record for use in research
• Benzer et al. conducted the first studies with fruit flies
• Since then, 4 approaches have been developed to study fruit flies in 
regard to neurodegeneration
Drosophila and the study of 
neurodegeneration
• Method 1: Isolating genes and mutations that lead to 
neurodegeneration (“forward screens”)
• Change up the phenotype (use different individuals) and observe 
which gene was making the difference
• RNA interference (RNAi) has allowed researchers to disrupt D. 
melanogaster genomes and observe which genes lead to maladaptive 
effects
Drosophila and the study of 
neurodegeneration
• Method 2: ”reverse screens”
• Alter the genotype, and observe the phenotype
• CRISPR/Cas9 can be used to edit the genome on a large scale with 
extreme precision
• This would only be ethical in simple organisms, however
• Discussion Question: Do you think that reverse screens would be 
ethical in humans? What about the prospects of CRISPR/Cas9 serving 
as a tool for making designer babies?
Drosophila and the study of 
neurodegeneration
• Method 3: Studying the fly’s eye
• D. melanogaster has a large, repetitive visual receptor array 
influenced by the health of feeding neurons
• If the visual receptors are altered, they can be observed and a 
“rough” appearance to the eye is common 
Drosophila and the study of 
neurodegeneration
• Method 4: Using enhancer-suppressor modifier genes
• Some genes are directly linked to certain phenotypes such as nerve 
toxicity
• However, other genes control the expression of the mutated genes, 
leading to higher or lower expression
• Altering or removing the modifier gene can increase or decrease the 
severity of a condition, or make the expression of the first gene out of 
control
• Inference: fighting tumorigenic modifier genes could serve as a 
disease-modifying treatment for cancer
What has been found using Drosophila?
• Forward screens of the fruit fly genome have found over 40 genes to 
the “recessive loss of functions” (like AD and PD)
• More than half of these genes have been found to be linked to 
neurodegeneration
• “This list underestimates the actual number of genes whose mutation 
may lead to a loss of integrity or function of the fly nervous system.”
• Evidence has shown that mutations of the parkin and pink1 genes are 
associated with PD
What has been found using Drosophila?
• One functional screen on the D. melanogaster genome has examined 
87 loss-of-function genes linked to Alzheimer's and found several 
modifier genes, including some that alter the presence of the Tau 
protein (leads to neurodegeneration through the amyloid-β peptide)
• In vivo studies in D. melanogaster have shown a linkage in APP (a 
precursor to the amyloid protein) and neuroanatomical defects linked 
to Alzheimer’s 
• Recent news: Aducanumab has recently been approved as a 
treatment for Alzheimer’s (June 7th)
What has been found using Drosophila?
• Fruit flies have also been used to identify 
that exon 1 of the Huntington’s gene is 
particularly pathogenic, making a potential 
target for therapy
• Similar neurodegeneration as shown on the 
left can be expected from the Huntington’s 
gene
Future prospects for the fly model
(identify pathways that lead to 
disease: the expression of X 
gene leading to the production 
of Y protein to lead to Z effect)
(generation of basic and applied 
research designs to test the 
involvement of the identified 
gene in neurodegeneration)
(potential application is isolating 
the protein coming from the 
identified gene and test whether it 
has effects on humans or mice)
(identify genetic targets for the 
development of drugs designed 
to deter the expression of the 
gene in clinical studies)
Future prospects for the fly model
• My interpretation of the diagram prior to this slide
• First the genetic origin of a particular phenotype or disease can be tested in 
D. melanogaster. Protective substances can also be tested for effectiveness 
against neurodegeneration
• Secondly, studies in higher-order, mammalian organisms such as mice or rats 
can be conducted
• Lastly, human trials can be conducted for effectiveness
Future prospects for the fly model
• Although the fly model most definitely is useful, it is not perfect
• Compared to humans, flies have relatively simple nervous systems, meaning 
they are not dependable for direct translation into human research (mice 
generally serve as the middle ground)
• Flies are arthropods while humans are vertebrates, marking a divergence in 
evolution. Thus, the disease-linked genes in flies may not be causative factors 
for neurodegeneration in humans
Future prospects of the fly model
• Although D. melanogaster differs from humans, it has a number of 
benefits still
• Its genome has been thoroughly mapped
• The protective role of various chemicals can be examined 
• Lithium use in fruit flies has been shown to suppress the accumulation of amyloid-β in 
the Alzheimer’s model
• Methylene blue (a common staining tool) has been shown to lower neurodegeneration 
in Huntington's’ patients
• A short peptide from Huttingtin has been shown to decrease the accumulation of the 
polyglutamine protein in the fly HD model
• It is the best-analyzed and best understood multicellular organism to date
Summary
• Molecular genetics has played a powerful role in allowing us to 
discover the effects of genetic mutations and conditions, as well as 
identify animal models for treatment development in humans
• D. melanogaster serves as a promising human alternative for testing 
in research trials
Discussion Questions
• Going back to the very reason for this study, diseases present 
themselves late in life. While many are unavoidable (such as HD Type 
II diabetes), many are avoidable. Should the government spend more 
money trying to encourage healthy living habits or fund research to 
produce treatments for avoidable diseases?
• Do you think that D. melanogaster serves as an adequate alternative 
to human in vivo trials? Would mice models suffice in their place?
• One of the foundational tools in the review was the use of molecular 
genetics. Do you think neurodegenerative diseases can be explained 
in light of evolution (genetics), or are the result of the present 
(modern medicine)?
Discussion Questions
• What do you think about the use of animal models in general? Is 
there an alternative way to coming up with drugs and treatments that 
does not involve harming animals?
• Based upon the findings in the review, what do you think would be 
some good follow-up experiments that would benefit the larger 
scientific community?
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